Pediatric Medication Therapy Management Trial for Children with Complex Conditions
This study is testing an intervention called Pediatric Medication Therapy Management (pMTM) to see if it can help identify and manage medication-related problems in children. pMTM involves a full review of your child's medications, making sure they are optimized, and creating a medication action plan. You may be able to join if your child is between 2 and 18 years old, has at least one complex chronic condition, takes five or more medications, and receives primary care at Children's Hospital Colorado. The study will measure success by looking at the number of medication-related problems after 90 days. The current recruitment status for this study is unclear.
- Study design
- This is an interventional study planning to enroll 371 participants. Participants will be randomly assigned to either receive usual care or the Pediatric Medication Therapy Management (pMTM) intervention.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Medication-related problems will be measured at 90 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pediatric Medication Therapy Management Trial
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- James A Feinstein, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Medication-Related Problem (MRP) Count90 Days
A MRP is a clearly defined event involving medication therapy that interferes with an optimum outcome for a specific patient, including: inappropriate or unnecessary therapy; suboptimal therapy; undertreated symptom; adverse drug event; major drug-drug interaction; duplication of therapy; or, unclear prescription instruction.